Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09)

~23 mi. (Tucson, Arizona, +266 more cities)

Research Site, +1 more facility

ERBB2 Amplification, +1 more biomarker

Breast Carcinoma

fam-trastuzumab deruxtecan, +2 more drugs

targeted therapy

Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)

~23 mi. (Tucson, Arizona, +176 more cities)

Arizona Oncology Associates PC- HOPE ( Site 3049)

Endometrial Carcinoma, +1 more condition

chemotherapy, +2 more drugs

chemotherapy, +2 more types

Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49)

~23 mi. (Tucson, Arizona, +89 more cities)

Arizona Oncology Associates-Arizona Oncology ( Site 0049)

ER Positive, +2 more biomarkers

Breast Carcinoma

capecitabine, +4 more drugs

chemotherapy, +1 more type

Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy

~23 mi. (Tucson, Arizona, +744 more cities)

University of Arizona Cancer Center-North Campus, +1 more facility

Breast Carcinoma

axillary lymph node dissection, +1 more drug

radiation therapy, +1 more type

Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer

~23 mi. (Tucson, Arizona, +269 more cities)

University of Arizona Cancer Center-Orange Grove Campus, +1 more facility

ER Positive, +1 more biomarker

Invasive Breast Carcinoma

radiation therapy, +1 more drug

radiation therapy

Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma

~23 mi. (Tucson, Arizona, +454 more cities)

University of Arizona Cancer Center-North Campus, +1 more facility

Classical Hodgkin Lymphoma

brentuximab vedotin, +7 more drugs

chemotherapy, +3 more types

A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia

~23 mi. (Tucson, Arizona, +173 more cities)

Banner University Medical Center - Tucson

B-Cell Lymphoblastic Leukemia/Lymphoma

asparaginase Erwinia chrysanthemi, +12 more drugs

chemotherapy, +2 more types

Sasanlimab (PF-06801591) in Combination With BCG or as Single Agent in Participants With High-Risk Non-Muscle Invasive Bladder Cancer

~23 mi. (Tucson, Arizona, +153 more cities)

Urological Associates of Southern Arizona, P.C ., +1 more facility

Bladder Urothelial Carcinoma, +2 more conditions

BCG solution, +1 more drug

immunotherapy

Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency

~23 mi. (Tucson, Arizona, +332 more cities)

Research Site

PTEN Deficient Expression

Prostate Adenocarcinoma

abiraterone, +1 more drug

hormone therapy, +1 more type

A Study of Chemo Only Versus Chemo Plus Nivo With or Without BMS-986205, Followed by Post- Surgery Therapy With Nivo or Nivo and BMS-986205 in Patients With MIBC

~23 mi. (Tucson, Arizona, +177 more cities)

Arizona Oncology Associates

Bladder Carcinoma

cisplatin, +3 more drugs

chemotherapy, +1 more type

Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)

~23 mi. (Tucson, Arizona, +130 more cities)

Arizona Institute of Urology (AIU) - Northwest ( Site 1096)

Bladder Urothelial Carcinoma

BCG solution, +1 more drug

immunotherapy

Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)

~23 mi. (Tucson, Arizona, +199 more cities)

The University of Arizona Cancer Center - North Campus ( Site 0039)

Hepatocellular Carcinoma

pembrolizumab

immunotherapy